BRAIN Biotech AG (FRA:BNN)

Revenue by Segment

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Brainbiocatalysts	45.80M	47.81M	-	-	-
Brainbiocatalysts Growth	-4.20%	-	-	-	-
BRAINBioincubator	4.41M	7.89M	944.00K	111.00K	-
BRAINBioincubator Growth	-44.03%	735.28%	750.45%	-	-
Consolidation	-	-194.00K	-39.00K	-118.00K	-159.00K
Bioproducts	-	-	42.64M	37.70M	28.30M
Bioproducts Growth	-	-	13.10%	33.24%	12.14%
Bioscience (excl. Bioincubator)	-	-	12.68M	12.60M	-
Bioscience (excl. Bioincubator) Growth	-	-	0.63%	-	-
Bio Science	-	-	-	-	11.09M
Bio Science Growth	-	-	-	-	-20.35%
Total	50.22M	55.50M	56.23M	50.30M	39.22M
Total Growth	-9.52%	-1.29%	11.79%	28.23%	0.41%

Revenue by Geography

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Germany	5.52M	6.65M	5.67M	7.93M	7.07M
Germany Growth	-17.10%	17.46%	-28.55%	12.17%	-20.62%
Other Abroad	16.48M	16.58M	16.47M	13.58M	10.70M
Other Abroad Growth	-0.62%	0.67%	21.27%	26.95%	5.07%
USA	12.30M	13.51M	15.31M	14.02M	8.86M
USA Growth	-8.95%	-11.71%	9.20%	58.17%	28.79%
Netherlands	8.85M	11.28M	10.38M	6.54M	4.98M
Netherlands Growth	-21.56%	8.70%	58.73%	31.30%	79.30%
United Kingdom	4.30M	3.68M	4.77M	3.64M	3.70M
United Kingdom Growth	16.79%	-22.83%	30.94%	-1.54%	-18.39%
France	2.18M	2.92M	2.74M	3.80M	3.08M
France Growth	-25.45%	6.42%	-27.78%	23.35%	-37.75%
Total	49.62M	54.63M	55.34M	49.51M	38.39M
Total Growth	-9.17%	-1.27%	11.77%	28.96%	0.43%

Source: S&P Global Market Intelligence.